GLENMARKFinancial ResultsBSE
Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of Glenmark Pharmaceuticals Limited ('The Company') For The Quarter And Half Year Ended September 30, 2026
Filed 23 October 2026 at 6:14 am · 23 Oct 2026
FILING SUBJECT
Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of Glenmark Pharmaceuticals Limited ('The Company') For The Quarter And Half Year Ended September 30, 2026